Document is current
Any future updates will be listed below
-
Authors
Tang, Nan
Li, Wendi
Shang, Hezhen
Yang, Zhen
Chen, Zengyin
Shi, Guangjun
-
Funding
Funding for this research was provided by:
Irisin in treating hyperlipidemic pancreatitis via the inhibition of the AKT-NF-kB pathway (2020-WJZD209)
- License Information
-
More Information
Article History
Received: 16 October 2024
Accepted: 27 December 2024
First Online: 17 January 2025
Compliance with ethical standards
:
: Approval for the study was obtained from the Medical Ethics Committee of Chengyang District People’s Hospital and Qingdao Municipal Hospital, following the International Convention on Ethics of Laboratory Animals and national regulations. And this study was conducted with the ARRIVE guidelines for animal experiments. Every effect was made to minimize animal suffering.
: The authors declare no competing interests.
